What is a stock summary page? Click here for an overview.
Business Description
Instituto Rosenbusch SA
ISIN : ARROSE010025
Share Class Description:
BUE:ROSE: Class B 1 VoteDescription
Instituto Rosenbusch SA is a pharmaceutical company based in Argentina. The company is engaged in the processing and industrialization of biological, chemical, pharmaceutical products of any kind, nature or destination, preferably for veterinary use or intended to combat pests and diseases of the agricultural exploitation. The company has line of products such as Biologicals and pharmaceuticals. Biologicals offer Campy 3, Cultivac 6M and Bovine Antibrucelosis. Pharmaceuticals offer Diclosan A Intrammamary, Diclosan S Intrammamary and Mastilina V-S.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.44 | |||||
| Equity-to-Asset | 0.49 | |||||
| Debt-to-Equity | 0.33 | |||||
| Debt-to-EBITDA | 2.2 | |||||
| Interest Coverage | 8.54 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 1.62 | |||||
| Beneish M-Score | 0.07 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 75.1 | |||||
| 3-Year EBITDA Growth Rate | 141.2 | |||||
| 3-Year FCF Growth Rate | 16.5 | |||||
| 3-Year Book Growth Rate | 71 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 30.24 | |||||
| 9-Day RSI | 28.63 | |||||
| 14-Day RSI | 30.5 | |||||
| 6-1 Month Momentum % | 0.21 | |||||
| 12-1 Month Momentum % | 34.68 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.43 | |||||
| Quick Ratio | 1.39 | |||||
| Cash Ratio | 0.22 | |||||
| Days Inventory | 322.46 | |||||
| Days Sales Outstanding | 76.17 | |||||
| Days Payable | 93.59 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -12.62 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 54.58 | |||||
| Operating Margin % | 45.39 | |||||
| Net Margin % | -2.3 | |||||
| FCF Margin % | 9.05 | |||||
| ROE % | -4.62 | |||||
| ROA % | -2.11 | |||||
| ROIC % | 88.98 | |||||
| 3-Year ROIIC % | 13.4 | |||||
| ROC (Joel Greenblatt) % | 3.31 | |||||
| ROCE % | 2.71 | |||||
| Years of Profitability over Past 10-Year | 4 |
GF Value Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio without NRI | 294.68 | |||||
| Price-to-Owner-Earnings | 12.6 | |||||
| PS Ratio | 0.8 | |||||
| PB Ratio | 1.15 | |||||
| Price-to-Tangible-Book | 1.14 | |||||
| Price-to-Free-Cash-Flow | 8.8 | |||||
| Price-to-Operating-Cash-Flow | 8.77 | |||||
| EV-to-EBIT | 48.85 | |||||
| EV-to-EBITDA | 9.08 | |||||
| EV-to-Revenue | 0.96 | |||||
| EV-to-FCF | 10.56 | |||||
| Price-to-GF-Value | 2.06 | |||||
| Price-to-Projected-FCF | 0.97 | |||||
| Price-to-Median-PS-Value | 1.18 | |||||
| Price-to-Graham-Number | 3.84 | |||||
| Price-to-Net-Current-Asset-Value | 2.14 | |||||
| Earnings Yield (Greenblatt) % | 2.06 | |||||
| FCF Yield % | 11.49 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Instituto Rosenbusch SA Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ARS) | 5,298.041 | ||
| EPS (TTM) (ARS) | -4.552 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | 1.25 | ||
| 3-Year Sortino Ratio | 3.09 | ||
| Volatility % | 69.28 | ||
| 14-Day RSI | 30.5 | ||
| 14-Day ATR (ARS) | 2.685451 | ||
| 20-Day SMA (ARS) | 106.53 | ||
| 12-1 Month Momentum % | 34.68 | ||
| 52-Week Range (ARS) | 82 - 125 | ||
| Shares Outstanding (Mil) | 42.59 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Instituto Rosenbusch SA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Instituto Rosenbusch SA Stock Events
| Event | Date | Price (ARS) | ||
|---|---|---|---|---|
| No Event Data | ||||
Instituto Rosenbusch SA Frequently Asked Questions
What is Instituto Rosenbusch SA(BUE:ROSE)'s stock price today?
The current price of BUE:ROSE is ARS98.00. The 52 week high of BUE:ROSE is ARS125.00 and 52 week low is ARS82.00.
When is next earnings date of Instituto Rosenbusch SA(BUE:ROSE)?
The next earnings date of Instituto Rosenbusch SA(BUE:ROSE) is .
Does Instituto Rosenbusch SA(BUE:ROSE) pay dividends? If so, how much?
Instituto Rosenbusch SA(BUE:ROSE) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers